Adam R. Kalbermatten, Chief Commercial Officer at KORU Medical Systems, Inc. (KRMD), bought 32,000 shares at $3.16 ($101K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Chief Commercial Officer Adam R. Kalbermatten purchased $101,120 worth of KRMD stock at $3.16, marking the largest insider purchase in the company's history. This significant bet by a key executive suggests confidence in the company's recent turnaround and profitability.
KRMD is trading near its 52-week low of $3.125, down 20.1% over the last 90 days and 51.88% from its high of $6.608, despite recent positive earnings momentum.
Q2 2026 earnings on August 6, 2026, where the company reported record revenue and first profitable quarter since 2019; the next earnings print on August 6, 2026, following a 150% earnings surprise in the prior quarter.
The stock faces a short interest risk of 2.06% of the float, and recent news highlights international headwinds and the withdrawal of the FESGO product, which could pressure margins.
Something here stands out, but not much.